iBio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of iBio generated cash of -$18,554,000, which is more than the previous year. Cash used in financing activities reached the amount of $24,494,000 last year. Net change in cash is therefore $6,846,000.
Cash Flow
| 2015 | -4.72M | -215K | 10.86M |
|---|---|---|---|
| 2016 | -8.07M | -68K | 21.66M |
| 2017 | -13.16M | -1.59M | -170K |
| 2018 | -13.48M | -1.07M | 22.40M |
| 2019 | -13.97M | -990K | 3.45M |
| 2020 | -13.34M | -1.15M | 65.19M |
| 2021 | -30.06M | -26.47M | 78.83M |
| 2022 | -37.48M | -5.12M | -6.12M |
| 2023 | -30.43M | 7.00M | 2.30M |
| 2024 | -18.55M | 906K | 24.49M |
IBIO Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7.57M | 28.67M | 77.40M | 55.11M | 4.42M | 15.93M | 8.08M | 23.01M | 9.49M | 3.59M |
Operating activities | ||||||||||
Net income | -24.90M | -65.01M | -50.30M | -23.21M | -16.44M | -17.59M | -16.10M | -16.13M | -10.65M | -6.62M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.25M | 1.38M | 3.79M | 2.41M | 2.24M | 1.74M | 1.70M | 1.67M | 940K | 363K |
Stock-based compensation expense | 2.03M | 4.39M | 4.37M | 1.58M | 388K | 241K | 0 | 1.01M | 1.24M | 914K |
| Deferred income tax benefit | 2.03M | 4.39M | 4.37M | 1.58M | 388K | 241K | 0 | 1.01M | 1.24M | 914K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 1M | -886K | -426K | 22K | -22K | 39K | 309K | -39K | -240K |
Inventories | 0 | -1.01M | -3.87M | 772K | -798K | -96K | 26K | -4K | -22K | -8.84M |
Accounts payable | -1.49M | -625K | 1.23M | 48K | 498K | 292K | 49K | -257K | -125K | 806K |
Cash generated by operating activities | -18.55M | -30.43M | -37.48M | -30.06M | -13.34M | -13.97M | -13.48M | -13.16M | -8.07M | -4.72M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -10.14M | -7.11M | -23.81M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -210K | -5.73M | -11.63M | -5.16M | -1.15M | -990K | -1.07M | -1.59M | -68K | -215K |
Acquisitions Net | 0 | -692K | -7.55M | -242K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 906K | 7.00M | -5.12M | -26.47M | -1.15M | -990K | -1.07M | -1.59M | -68K | -215K |
Financing activities | ||||||||||
Common Stock Issued | 25.52M | 11.48M | 77K | 78.27M | 62.36M | 1.35M | 21.62M | 12.49M | 6.22M | 10M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -7K | -39K | 0 | 0 | -40.80M | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.13M | -9.12M | -5.83M | -331K | -2.06M | -197K | -183K | -170K | -565K | 0 |
Cash used in financing activities | 24.49M | 2.30M | -6.12M | 78.83M | 65.19M | 3.45M | 22.40M | -170K | 21.66M | 10.86M |
Net Change In Cash | 6.84M | -21.09M | -48.73M | 22.29M | 50.69M | -11.51M | 7.84M | -14.92M | 13.52M | 5.90M |
Cash at end of period | 14.42M | 7.57M | 28.67M | 77.40M | 55.11M | 4.42M | 15.93M | 8.08M | 23.01M | 9.49M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |